Clinical Efficacy of Follitropin Alfa in GnRH-Antagonist Protocols: A Prospective Observational Phase IV Study on the Use of Biosimilar Follitropin Alfa r-hFSH in Assisted Reproductive Technology in a Routine Care Setting

BACKGROUND: This phase IV routine care study evaluated ovarian responses when using a biosimilar follitropin alfa r-hFSH (Bemfola(®)) for controlled ovarian stimulation (COS) in women undergoing assisted reproductive technology (ART) treatment who were pituitary-suppressed with a gonadotrophin-relea...

Descripción completa

Detalles Bibliográficos
Autores principales: Griesinger, Georg, Schill, Thilo, Sator, Michael, Schenk, Michael, Krüssel, Jan-Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143010/
https://www.ncbi.nlm.nih.gov/pubmed/34041008
http://dx.doi.org/10.18502/jri.v22i2.5798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143010/
https://www.ncbi.nlm.nih.gov/pubmed/34041008
http://dx.doi.org/10.18502/jri.v22i2.5798

Ejemplares similares